Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS
· Delayed Price · Currency is USD
6.53
+0.73 (12.59%)
At close: May 2, 2025
Sumitomo Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 23,634 | -314,929 | -96,714 | 40,600 | 36,829 | Upgrade
|
| Depreciation & Amortization | 25,562 | 37,765 | 41,263 | 38,348 | 22,673 | Upgrade
|
| Loss (Gain) From Sale of Assets | -13,537 | 180,857 | 75,850 | 769 | 18,989 | Upgrade
|
| Asset Writedown & Restructuring Costs | 5,189 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -5,890 | -24,735 | - | - | Upgrade
|
| Other Operating Activities | -5,578 | -37,226 | -25,236 | -41,871 | -34,818 | Upgrade
|
| Change in Accounts Receivable | -909 | 23,390 | 51,218 | -6,097 | 185 | Upgrade
|
| Change in Inventory | 18,837 | -11,795 | 4,560 | 5,356 | -10,039 | Upgrade
|
| Change in Accounts Payable | -25,868 | 5,645 | 5,318 | -28,669 | -320 | Upgrade
|
| Change in Unearned Revenue | -25,822 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 14,992 | -119,710 | -19,587 | 22,803 | 102,102 | Upgrade
|
| Operating Cash Flow | 16,500 | -241,893 | 11,937 | 31,239 | 135,601 | Upgrade
|
| Operating Cash Flow Growth | - | - | -61.79% | -76.96% | 193.97% | Upgrade
|
| Capital Expenditures | -8,498 | -10,771 | -8,467 | -7,347 | -6,048 | Upgrade
|
| Sale of Property, Plant & Equipment | 2,208 | 434 | 1,322 | 1,313 | 21,520 | Upgrade
|
| Divestitures | 1,458 | 8,605 | 30,172 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -3,804 | -4,959 | 7,840 | -6,147 | -4,758 | Upgrade
|
| Investment in Securities | 106,846 | 29,727 | 3,821 | -6,433 | -1,225 | Upgrade
|
| Other Investing Activities | 1,544 | - | 2,047 | -797 | 225 | Upgrade
|
| Investing Cash Flow | 99,754 | 33,036 | 52,419 | -18,278 | 8,875 | Upgrade
|
| Short-Term Debt Issued | - | 84,000 | 85,559 | 29 | - | Upgrade
|
| Long-Term Debt Issued | 146,187 | - | - | - | 243,927 | Upgrade
|
| Total Debt Issued | 146,187 | 84,000 | 85,559 | 29 | 243,927 | Upgrade
|
| Short-Term Debt Repaid | -181,972 | - | - | - | -265,000 | Upgrade
|
| Long-Term Debt Repaid | -73,614 | - | -20,060 | -4,960 | -2,960 | Upgrade
|
| Total Debt Repaid | -255,586 | - | -20,060 | -4,960 | -267,960 | Upgrade
|
| Net Debt Issued (Repaid) | -109,399 | 84,000 | 65,499 | -4,931 | -24,033 | Upgrade
|
| Common Dividends Paid | -3 | - | - | - | - | Upgrade
|
| Dividends Paid | -3 | -2,792 | -11,125 | -11,126 | -11,120 | Upgrade
|
| Other Financing Activities | 566 | -3,357 | -201,191 | -5,369 | -22,062 | Upgrade
|
| Financing Cash Flow | -108,836 | 77,851 | -146,817 | -21,426 | -57,215 | Upgrade
|
| Foreign Exchange Rate Adjustments | -177 | 15,440 | 24,090 | 17,751 | 4,729 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -13,172 | 1,135 | -1,135 | - | - | Upgrade
|
| Net Cash Flow | -5,931 | -114,431 | -59,506 | 9,286 | 91,990 | Upgrade
|
| Free Cash Flow | 8,002 | -252,664 | 3,470 | 23,892 | 129,553 | Upgrade
|
| Free Cash Flow Growth | - | - | -85.48% | -81.56% | 237.33% | Upgrade
|
| Free Cash Flow Margin | 2.01% | -80.32% | 0.63% | 4.27% | 25.11% | Upgrade
|
| Free Cash Flow Per Share | 20.14 | -635.97 | 8.73 | 60.14 | 326.09 | Upgrade
|
| Cash Interest Paid | 4,361 | 3,734 | 2,424 | 2,500 | 2,229 | Upgrade
|
| Cash Income Tax Paid | -12,182 | 37,595 | 25,450 | 42,331 | 35,035 | Upgrade
|
| Levered Free Cash Flow | -12,362 | -253,962 | 45,988 | 15,575 | 85,101 | Upgrade
|
| Unlevered Free Cash Flow | -3,925 | -251,529 | 47,638 | 17,431 | 86,624 | Upgrade
|
| Change in Net Working Capital | 25,324 | 51,604 | -85,970 | 44,902 | -40,820 | Upgrade
|
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.